REFIRE(02570)
Search documents
港股重塑能源跌近9%
Mei Ri Jing Ji Xin Wen· 2026-02-02 06:48
Group 1 - The stock of ReNew Energy (02570.HK) fell nearly 9%, reaching a historical low of 48.06 HKD [2] - As of the report, ReNew Energy was down 8.67%, trading at 48.22 HKD, with a trading volume of 54.848 million HKD [2] - The total market capitalization of ReNew Energy is now below 5 billion HKD [2]
重塑能源跌近9%创历史新低 总市值不足50亿港元 近期配股净筹2.58亿港元
Zhi Tong Cai Jing· 2026-02-02 06:39
Core Viewpoint - Reshape Energy (02570) has seen a significant decline in its stock price, reaching a historical low of 48.06 HKD, with a market capitalization of less than 5 billion HKD [1] Group 1: Stock Performance - The stock dropped nearly 9%, trading at 48.22 HKD with a trading volume of 54.848 million HKD [1] - The decline reflects investor concerns, as the company’s market value has fallen below 5 billion HKD [1] Group 2: Recent Announcements - Reshape Energy announced the completion of a placement of 4.536 million shares, raising a net amount of 258 million HKD [1] - 50% of the raised funds are intended for repaying bank loans and lease liabilities, while the remainder will be used for general corporate purposes [1] Group 3: Industry Insights - Reshape Energy is recognized as a leader in fuel cells, with expectations of rapid technological advancements and cost reductions in the sector [1] - According to CICC, the total lifecycle cost of fuel cell heavy trucks is anticipated to reach parity gradually after 2028 [1]
哈尔滨电气上一财年净赚超26亿元 中国电力2025年总售电量同比下滑
Xin Lang Cai Jing· 2026-01-26 12:48
Company News - China Power (02380.HK) expects a total consolidated electricity sales volume of 10.73105 million MWh by December 2025, a decrease of 2.31% year-on-year; the total annual electricity sales volume is approximately 126 million MWh, down 1.27% year-on-year [2] - Harbin Electric (01133.HK) anticipates a net profit attributable to shareholders of approximately RMB 2.65 billion for the fiscal year 2025, compared to RMB 1.686 billion in the previous year, mainly due to increased operating revenue and improved product profitability [2] - Singularity Guofeng (01280.HK) has entered into a GPU distribution cooperation agreement with Muxi Co., aiming to enter the domestic AI computing power market [2] - Dongyang Sunshine Pharmaceutical (06887.HK) has signed a strategic cooperation agreement with Shenzhen Jingtai to establish a joint venture for building an AI-driven drug research and development platform [2] - Weisheng Pharmaceutical-B (02561.HK) has received approval from the National Medical Products Administration for the marketing authorization application of injectable Long Pei growth hormone [2] - Kintor Pharmaceutical-B (02171.HK) issued a profit warning, expecting a net loss for 2025 to be reduced to no more than approximately RMB 120 million [2] - Zhaoke Ophthalmology-B (06622.HK) is advancing the commercialization process of BRIMOCHOL PF for treating presbyopia in Singapore and Vietnam through partnerships with AFT and Qianshou [2] Additional Company Developments - Heng Rui Medicine (01276.HK) has received a clinical trial approval notice for SHR-1049 injection [3] - Baolong Real Estate (01238.HK) has had its bond restructuring plan approved by the relevant bondholders' meeting [3] Strategic Partnerships - Yabo Technology Holdings (08279.HK) has entered into a technical service agreement with Hong Kong Gold Exchange Limited [4] - Future Data Group (08229.HK) has signed a strategic cooperation framework agreement with Linghe Culture [4] - Howey Group (00501.HK) plans to invest up to USD 50 million to subscribe for shares in Aixin Yuanzhi's initial public offering [4] Buyback Activities - Xiaomi Group-W (01810.HK) repurchased 3.9872 million shares for HKD 140 million, with a repurchase price ranging from HKD 35.04 to HKD 35.22 [5] - China Metallurgical Group (01618.HK) repurchased 9.011 million shares for HKD 16.9299 million, with a repurchase price of HKD 1.87 to HKD 1.88 [5] - Geely Automobile (00175.HK) repurchased 4.401 million shares for HKD 72.952 million, with a repurchase price ranging from HKD 16.43 to HKD 16.65 [6] - Reshape Energy (02570.HK) completed the placement of a total of 4.536 million placement shares, raising approximately HKD 258 million [6] - Kintor Pharmaceutical-B (09939.HK) saw an increase of 4.7 million shares by Chairman Tong Youzhi [6]
重塑能源完成配售合共453.6万股配售股份,净筹约2.58亿港元
Zhi Tong Cai Jing· 2026-01-26 09:23
配售事项所得款项总额及所得款项净额(经扣除配售事项佣金及配售事项的其他相关成本及开支后)分别 约为2.65亿港元及2.58亿港元,相当于净发行价为每股配售股份约56.96港元。 本公司拟将配售事项所得款项净额分配至以下用途:约50%的配售事项所得款项净额或约1.29亿港元将 用于通过偿还未偿还银行贷款及租赁负债而优化本集团财务结构;及约50%的配售事项所得款项净额或 约1.29亿港元将用于一般公司用途。预期配售事项所得款项净额将于2026年12月31日或之前悉数动用。 453.6万股配售股份相当于紧接交割前本公司已发行H股(不包括库存股份)数目的约7.88%及已发行股份 (不包括库存股份)数目的约5.12%;以及经配发及发行配售股份扩大后已发行H股(不包括库存股份)数目的 约7.30%及已发行股份(不包括库存股份)数目的约4.87%。 重塑能源(02570)发布公告,配售协议所载全部条件已获达成且交割已于2026年1月26日落实。配售代理 已按每股配售股份58.38港元的配售价成功向不少于六名承配人配售合共453.6万股配售股份。 ...
重塑能源(02570.HK):成功配售合共453.6万股 净筹2.58亿港元
Ge Long Hui· 2026-01-26 09:23
格隆汇1月26日丨重塑能源(02570.HK)发布公告,配售协议所载全部条件已获达成且交割已于2026年1月 26日落实。配售代理已按每股配售股份58.38港元的配售价成功向不少于六名承配人配售合共453.6万股 配售股份。配售事项所得款项总额及所得款项净额分别约为2.648亿港元及2.584亿港元。 ...
重塑能源(02570) - 翌日披露报表
2026-01-26 09:23
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 上海重塑能源集團股份有限公司 呈交日期: 2026年1月26日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02570 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | | 庫存股份變動 | | | | 事件 | | 已發行股份(不包括庫存股份)數 目 | ...
重塑能源(02570)完成配售合共453.6万股配售股份,净筹约2.58亿港元
智通财经网· 2026-01-26 09:22
Core Viewpoint - The company, 重塑能源 (02570), has successfully completed a placement agreement, with the delivery executed on January 26, 2026, raising approximately HKD 265 million in total proceeds [1] Group 1: Placement Details - The placement involved the successful sale of 4.536 million shares at a price of HKD 58.38 per share, representing about 7.88% of the company's issued H shares prior to the placement [1] - After the issuance of the placement shares, the total issued H shares will increase, resulting in approximately 7.30% of the newly issued H shares and about 4.87% of the total issued shares [1] Group 2: Financial Impact - The total proceeds from the placement are approximately HKD 265 million, with a net amount of about HKD 258 million after deducting commissions and related costs [1] - The net issuance price per share is approximately HKD 56.96 [1] Group 3: Use of Proceeds - The company plans to allocate approximately 50% of the net proceeds, or about HKD 129 million, to optimize its financial structure by repaying outstanding bank loans and lease liabilities [1] - The remaining 50% of the net proceeds, also around HKD 129 million, will be used for general corporate purposes [1] - The company expects to fully utilize the net proceeds by December 31, 2026 [1]
重塑能源(02570) - 根据一般授权配售新H股交割
2026-01-26 09:17
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 本公告僅供參考,並不構成收購、購買或認購任何證券的邀請或要約,亦並非擬用作邀請提出 相關要約或邀請。本公告或其任何副本概不得直接或間接帶入美國(包括其領土及屬地、美國 任何州及哥倫比亞特區)或於美國派發。尤其是,本公告並不構成亦並非在美國或其他地方出 售任何證券的要約或招攬購買或認購任何證券的任何要約。除非已根據1933年美國證券法(經 修訂)登記或獲豁免登記,否則證券不得在美國提呈發售或出售。於美國進行的任何證券公開 發售將僅以招股章程的方式進行,該招股章程可向證券發行人或賣方取得,並載有發行人及其 管理層的詳細資料以及財務資料。本公司無意於美國公開發售本公告所述證券。 SHANGHAI REFIRE GROUP LIMITED 上海重塑能源集團股份有限公司 (於中華人民共和國註冊成立的股份有限公司) (股份代號:2570) 根據一般授權配售新H股交割 1 4,536,000股配售股份相當於緊接交割前 ...
重塑能源跌5%,创历史新低
Ge Long Hui A P P· 2026-01-26 08:05
格隆汇1月26日|港股市场重塑能源(2570.HK)盘中跌5%,报56.05港元,股价创历史新低,总市值跌至 49.7亿港元。 ...
重塑能源(02570.HK)跌超4%
Mei Ri Jing Ji Xin Wen· 2026-01-20 06:28
每经AI快讯,重塑能源(02570.HK)跌超4%,盘中低见57.4港元,创上市新低,2025年12月初至今股价腰 斩。截至发稿,重塑能源跌4.47%,报57.65港元,成交额6882.94万港元。 ...